Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1032-1039

  Clerbaux, Gaëtan ^a   Francart, Julie ^a   Wallemacq, Pierre ^a   Robert, Annie ^a   Goffin, Eric ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Angiotensin converting enzyme inhibitors; Body surface area; Icodextrin; Mass transfer area coefficient of creatinine; Peritoneal equilibration test; Sodium sieving

Indexed keywords

ALPHA 2 MACROGLOBULIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; ICODEXTRIN; SERUM ALBUMIN;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY SURFACE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DIALYSATE; DRUG USE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SOLUTE; ULTRAFILTRATION;

ALPHA-MACROGLOBULINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL TRANSPORT; BODY SURFACE AREA; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; SERUM ALBUMIN; ULTRAFILTRATION;

EID: 33645297104     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi344     Document Type: Article

References (23)

1. Gokal R. Taking peritoneal dialysis beyond the year 2000. Perit Dial Int 1999; 19: S35-S42
2. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138-147
3. ISPD ad hoc committee on ultrafiltration management in peritoneal dialysis. Perit Dial Int 2000; 20 [Suppl 4]: S3-S4
4. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-325
5. Goffin E, Combet S, Jamar F et al. Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 1999; 33: 383-388
6. Stoenoiu MS, Ni J, Verkaeren C et al. Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum. J Am Soc Nephrol 2003; 14: 555-560
7. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992; 7: 50-56
8. Smit W, van Dijk P, Langedijk MJ et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440-449
9. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320-1332
10. Smit W, Langedijk MJ, Schouten N et al. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function. Perit Dial Int 2000; 20: 734-741
11. Churchill DN, Thorpe KE, Nolph KD et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285-1292
12. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17: 1085-1092
13. Pecoits-Filho R, Araujo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486
14. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66: 2437-2445
15. Gillerot G, Goffin E, Michel C et al. Genetic and clinical factor influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487
16. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004; 43: 492-501
17. Duman S. The renin-angiotensin system and peritoneal dialysis. Perit Dial Int 2004; 24: 5-9
18. Selgas R, Bajo MA, Cirugeda A et al. Ultrafiltration and small solute transport at initiation of PD: Questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25: 68-76
19. Heaf JG, Sarac S, Afzal S. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 2194-2201
20. Struijk DG, Krediet RT, Koomen GC et al. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45: 1739-1744
21. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051
22. Combet S, Miyata T, Moulin P et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11: 717-728
23. Davies SJ, Brown EA, Frandsen NE et al. Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67: 1609-1615